Am J Nephrol
- RANDHAY A, Selby NM, Taal MW, Eldehni MT, et al
Associations of body composition biomarkers with survival, cardiovascular events
and progression in persons with chronic kidney disease: insights from Renal Risk
in Derby Study.
Am J Nephrol. 2026 Jun 2:1-18. doi: 10.1159/000552844.
Clin J Am Soc Nephrol
- LIU A, Sonti P, Green JA, Koncicki HM, et al
How I Treat People with Kidney Failure on Chronic Dialysis Near End of Life.
Clin J Am Soc Nephrol. 2026 Apr 30. doi: 10.2215/CJN.0000001105.
Clin Nephrol
- HUANG J, Luo H, Du C, Zhai Q, et al
Antibody-drug conjugate therapy in a renal transplant patient with bladder
cancer: A case report.
Clin Nephrol. 2026 Jun 3. doi: 10.5414/CN111972.
Int J Artif Organs
- LI Z, Liu K
Clinical efficacy of anticoagulants in patients with uremic cerebral hemorrhage
receiving continuous renal replacement therapy.
Int J Artif Organs. 2026 Jun 4:3913988251318901. doi: 10.1177/03913988251318901.
J Am Soc Nephrol
- WEISS JW, Hall R, Saeed F, Callahan MB, et al
Executive Summary of ASN Kidney Health Guidance on Conservative Management in
People with Kidney Failure.
J Am Soc Nephrol. 2026;37:1287-1290.
- WILKIE M, Heimburger O, de Leon C, Carlsson O, et al
Ultrafiltration and Sodium Removal in Steady Concentration Peritoneal Dialysis: A
Prospective, Multicenter, Randomized, Crossover Study.
J Am Soc Nephrol. 2026 Jun 4. doi: 10.1681/ASN.0000001152.
- WONG SPY, Schell JO, Bursic AE, Butler CR, et al
ASN Kidney Health Guidance on Conservative Management in People with Kidney
Failure.
J Am Soc Nephrol. 2026;37:1291-1303.
J Nephrol
- VILLARROEL P, Arancibia M, Lorca E, Ardiles L, et al
Case report: nutritional intervention supplemented with ketoanalogues in chronic
kidney disease during pregnancy.
J Nephrol. 2026 Jun 2:aajag018. doi: 10.1093.
- D'ALESSANDRO C, Brambilla Pisoni M, Pagnucci S, Del Grosso A, et al
Accuracy of SARC-F test for screening of sarcopenia in adult dialysis patients.
J Nephrol. 2026 Jun 5:aajaf072. doi: 10.1093.
- ARAMPATZIS S, Ernandez T, Teta D, Bonani M, et al
New insights into the management of secondary hyperparathyroidism in non-dialysis
dependent chronic kidney disease: extended release calcifediol.
J Nephrol. 2026 Jun 2:aajaf008. doi: 10.1093.
- WONG L, Schembri E, McMahon LP
Frailty and sarcopenia in dialysis patients: a double burden with clinical
impact.
J Nephrol. 2026 Jun 2:aajaf073. doi: 10.1093.
J Ren Nutr
- ARGENTINO G, Paribello G, Borrelli S
Letter to the Editor on "Synbiotic Supplementation for Chronic Constipation in
Patients Under Peritoneal Dialysis: An Italian Multicenter Prospective Study".
J Ren Nutr. 2026 Jun 1:S1051-2276(26)00099-3. doi: 10.1053/j.jrn.2026.
- PANG H, Liao W, Zhang H, Wang S, et al
Stable heavy body shape throughout the life course increases the risk of chronic
kidney disease.
J Ren Nutr. 2026 Jun 3:S1051-2276(26)00106-8. doi: 10.1053/j.jrn.2026.
Lancet
- LEES JS, Skoberne A, Zhang L, Wyatt C, et al
Chronic kidney disease, complex conditions, and advancing therapeutics: new hope
and challenges.
Lancet. 2026 Jun 3:S0140-6736(26)00653-7. doi: 10.1016/S0140-6736(26)00653.
- LEES JS, Zhang L, Anandh U, Kronbichler A, et al
Advances in the diagnosis and detection of chronic kidney disease.
Lancet. 2026 Jun 3:S0140-6736(26)00702-6. doi: 10.1016/S0140-6736(26)00702.
N Engl J Med
- HEERSPINK HJL, Neuen BL, Agarwal R, Cherney DZI, et al
Finerenone in Persons with Chronic Kidney Disease without Diabetes.
N Engl J Med. 2026 Jun 4. doi: 10.1056/NEJMoa2604625.
- HEERSPINK HJL, McGill J, Lawatscheck R
Finerenone in Type 1 Diabetes and Chronic Kidney Disease. Reply.
N Engl J Med. 2026;394:2171-2172.
- GRANATA A, Corrao S
Finerenone in Type 1 Diabetes and Chronic Kidney Disease.
N Engl J Med. 2026;394:2171.
- GONZALEZ FM
Finerenone in Type 1 Diabetes and Chronic Kidney Disease.
N Engl J Med. 2026;394:2170-2171.
- SHAMIM MA, Varthya SB, Singh S
Finerenone in Type 1 Diabetes and Chronic Kidney Disease.
N Engl J Med. 2026;394:2170.
Pediatr Nephrol
- MUNIZ VM, de Paiva Souza Klippel L, Freitas KLF, Dos Santos Barbosa K, et al
Clinical complications and anthropometric indicators of chronic kidney disease in
a global context: scoping review.
Pediatr Nephrol. 2026 Jun 5. doi: 10.1007/s00467-026-07381.
- KRISHNAPRADEEP S, Abeyagunawardena IA, Chandrajith R, Abeyagunawardena AS, et al
Paediatric chronic kidney disease of unknown aetiology: early-life origins,
detection, and prevention.
Pediatr Nephrol. 2026 Jun 2. doi: 10.1007/s00467-026-07377.
- DEW S, Widger K, Rapoport A, Chanchlani R, et al
Adaptation and evaluation of PRO-Kid (patient-reported outcome measure for the
assessment of symptoms burden in pediatric chronic kidney disease) for children
aged 2-7 years.
Pediatr Nephrol. 2026 Jun 1. doi: 10.1007/s00467-026-07372.
Ren Fail
- FANG Y, Jiang Q, Zeng R, Gan X, et al
Influencing factors of oral frailty in Chinese maintenance hemodialysis patients:
a Bayesian network analysis.
Ren Fail. 2026;48:2673605.
- ELSAYED E, Kotb KM, Abdel-Salam El-Awady M, Samy M M, et al
Antihypertensive drugs and arteriovenous fistula flow rates among patients on
maintenance hemodialysis in Egypt.
Ren Fail. 2026;48:2670067.
- HOU YC, Chuang YC, Cheng YW, Huang HY, et al
Analytical and clinical validation of a competitive ELISA for serum indoxyl
sulfate and its clinical association with chronic kidney disease risk
stratification.
Ren Fail. 2026;48:2679793.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016